I see revenue a lot higher than UBS predictions as well for Fy25. Even if illuccix sales in US grows at 10 per cent per quarter I see revenue of 810 plus this year. That should grow to 1m plus next year just with further growth in the US with illuccix.
The market is not factoring in EU or Uk sales of illuccix or the approval to sell zircaix and also pixclara. If these catalysts come to fruition then I see a doubling or current share price plus more by end of Fy25
Short Term trading, analysis and TLX noise - No investors keep out, page-510
-
- There are more pages in this discussion • 252 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.48 |
Change
0.030(0.15%) |
Mkt cap ! $6.854B | |||
| Open | High | Low | Value | Volume |
| $20.35 | $20.83 | $20.30 | $10.68M | 520.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1586 | $20.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.58 | 898 | 2 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| TLX (ASX) Chart |